Compare BRNS & HHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRNS | HHS |
|---|---|---|
| Founded | 2016 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.9M | 21.2M |
| IPO Year | 2021 | 1994 |
| Metric | BRNS | HHS |
|---|---|---|
| Price | $0.54 | $2.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 28.6K | 3.5K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.35 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $159,570,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.51 | $2.22 |
| 52 Week High | $2.91 | $5.39 |
| Indicator | BRNS | HHS |
|---|---|---|
| Relative Strength Index (RSI) | 50.04 | 43.40 |
| Support Level | $0.56 | $2.33 |
| Resistance Level | $0.76 | $3.03 |
| Average True Range (ATR) | 0.05 | 0.08 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 52.38 | 50.00 |
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.